<DOC>
	<DOCNO>NCT00021346</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness combine carboplatin gemcitabine treat patient advance solid tumor .</brief_summary>
	<brief_title>Carboplatin Gemcitabine Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose gemcitabine carboplatin patient advance solid tumor . II . Determine dose-limiting toxic effect regimen patient . III . Evaluate pharmacokinetics pharmacodynamics regimen patient . IV . Determine observe response patient receive regimen . OUTLINE : This dose-escalation study gemcitabine . Patients stratify accord prior therapy ( prior chemotherapy and/or prior radiotherapy less 20 % bone marrow v prior chemotherapy and/or prior radiotherapy least 20 % bone marrow ) . Patients receive carboplatin IV 30 minute day 1 gemcitabine IV 30 minute day 1 8 . Treatment repeat every 21 day absence disease progression unacceptable toxicity . Cohorts 1-3 patient receive escalate dos gemcitabine maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 patient experience dose-limiting toxicity . Patients follow survival . PROJECTED ACCRUAL : A maximum 18 patient ( 9 per stratum ) accrue study .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced solid tumor standard therapy exist No untreated brain metastasis evidence neurologic deterioration CNS progression PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : More 3 month Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 5 time upper limit normal Renal : Creatinine great 1.5 mg/dL Other : No serious concurrent infection No serious concurrent medical illness would preclude study Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 3 month study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No 2 prior systemic chemotherapy regimen advance disease Prior adjuvant induction therapy initial disease allow At least 4 week since prior chemotherapy ( 6 week nitrosoureas , mitomycin , melphalan ) No prior combination carboplatin gemcitabine Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy 30 % bone marrow At least 4 week since prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>